Digma Medical
Digma Medical Ltd. is a clinical-stage Israeli medical device company developing the EGAD, a laser-based balloon-catheter system for minimally invasive ablation of Barrett's Esophagus, targeting hospital gastroenterology departments and outpatient endoscopy centers through an investigational-use-only program.
- Company typePrivate
- Founded2013
- HeadquartersPetah Tiqva, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Digma Medical does
Digma Medical Ltd. is a clinical-stage medical device company developing the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive laser-based balloon-catheter system intended for the treatment of Barrett's Esophagus—a pre-cancerous condition that can progress to esophageal adenocarcinoma. The EGAD platform delivers contactless, depth-controlled laser ablation through a single-use catheter passed via the working channel of standard GI endoscopes, using a proprietary dual-wavelength guidance system (a visible red pointer for targeting and an NIR therapeutic laser for ablation) with a balloon-centered design that stabilizes delivery. The procedure is designed for the standard GI endoscopy suite without requiring additional imaging equipment or fluoroscopy.
The company's commercial model targets hospital gastroenterology departments and outpatient endoscopy centers and is structured as a capital-plus-consumables offering: an EGAD treatment console paired with single-use catheters whose recurring per-procedure use generates a razor-and-blade revenue stream. The Digma System is investigational-only and not approved for sale in any geography; pricing is not publicly disclosed and go-to-market relies on direct enterprise sales, scientific advisory engagement (led by Prof. Ohad Etzion, Director of GI at Soroka), and medical conference presence. The company is privately held, headquartered at Ha'arava St 1, Giv'at Shmuel, Israel, with an 11–50 employee footprint, and is backed by Accelmed, Arkin Holdings, Peregrine Ventures, MedTech Innovator, and Israel's Office of the Chief Scientist across rounds dated 2013, 2015, 2016, 2022, and 2023 (amounts undisclosed).
Leadership combines deep medical-device operating experience with venture capital reach. Co-founder and CTO Ilan Ben-Oren is the author of more than 60 patents and previously founded or served as CTO at Eximo Medical (acquired by AngioDynamics), Exalenz Bioscience (acquired by Meridian BioScience), and Oridion Medical (acquired by Covidien). Co-founder Dr. Irit Yaniv is Founding Partner and CEO of Almeda Ventures and Managing Partner at Accelmed Ventures II. General Manager Shlomit Chappel-Ram, PhD, MBA, previously held senior roles at Nano Dimension, Edwards Lifesciences, and Medinol. Board Chairman Chris Rowland is a 35+ year MedTech executive with prior companies acquired by Covidien/Medtronic, Teleflex, and a Chinese strategic.
Digma Medical firmographics
Firmographics- Name
- Digma Medical
- Legal name
- Digma Medical, Ltd.
- Website
- https://digmamedical.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Digma Medical Ltd. is a clinical-stage Israeli medical device company developing the EGAD, a laser-based balloon-catheter system for minimally invasive ablation of Barrett's Esophagus, targeting hospital gastroenterology departments and outpatient endoscopy centers through an investigational-use-only program.
- Ownership category
- akta.pro rank
Digma Medical industry classification
Industry- Product category
- Endoscopic Gastrointestinal Ablation Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools) (HLAHADAN)
- akta.pro secondary industries
- Endoscopy & GI Procedure Centers (HLAFAIAE), Gastrointestinal Oncology (HLAKAFAK)
Keywords
Where Digma Medical is headquartered
LocationHeadquarters
- HQ city
- Petah Tiqva
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Digma Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- EGAD Console: Capital equipment sale of EGAD treatment console to hospitals and GI endoscopy centers
- Single-use Catheters: Recurring consumable revenue from single-use catheters compatible with the console, providing recurring revenue stream tied to procedure volume
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
Digma Medical product offering
Product offeringCore offering
Digma Medical develops and intends to commercialize the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive, laser-based balloon-catheter system for treating Barrett's Esophagus. The system comprises an EGAD Console (capital equipment) and a single-use balloon catheter delivered through the working channel of standard GI endoscopes, enabling contactless, uniform, depth-controlled tissue ablation that protects deeper layers such as the muscularis. The product is currently investigational and not yet available for sale.
Product overview
Digma Medical offers a unified medical device system called the Endoscopic Gastrointestinal Ablation Device (EGAD), consisting of two integrated components: an EGAD Console and an EGAD Single-use Catheter. The system provides contactless, uniform, depth-controlled laser ablation for Barrett's Esophagus treatment, designed for use in standard GI endoscopy suites without requiring additional imaging equipment.
Differentiator
Problem solved
Functional benefit
Products and services
- Endoscopic Gastrointestinal Ablation Device (EGAD) System A minimally invasive, laser-based balloon-catheter system for treating Barrett's Esophagus, comprising a console and a single-use catheter that delivers contactless, uniform, depth-controlled ablation guided by imaging and is compatible with standard GI endoscopes. Targeted at hospital gastroenterology departments and outpatient endoscopy centers.
- EGAD Console Capital equipment component of the EGAD system that delivers laser energy via the single-use catheter. Designed for use in standard GI endoscopy suites without requiring additional imaging equipment or fluoroscopy.
- EGAD Single-use Catheter Single-use balloon-catheter delivered through the working channel of standard GI endoscopes, featuring balloon-centered laser delivery for stable, contactless, depth-controlled ablation with selective tissue interaction. Designed as a recurring consumable tied to procedure volume.
Quantifiable outcome
- Increases risk of esophageal adenocarcinoma by up to 125x without treatment
- +2 more outcomes
Companies that use Digma Medical
Customer profileSegments2 records
Ideal customer profiles1 record
Digma Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Digma Medical partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
Digma Medical competitors and assessment
Company assessmentBroad incumbents
- Medtronic: Owner of the Barrx radiofrequency ablation system, the dominant endoscopic BE ablation platform. Directly competes with Digma's EGAD in the same GI procedure setting and represents the primary incumbent Digma must displace for share.
- ERBE Elektromedizin: German manufacturer of electrosurgical and therapeutic endoscopy platforms widely used in GI ablation and resection procedures. Comparable as a broad incumbent energy-based endoscopy equipment vendor that GI departments already procure from.
- Olympus Corporation: Global leader in GI endoscopy systems and accessories, including the scope platforms through which EGAD is delivered. Comparable as the dominant incumbent in GI endoscopy suites where Digma's product is designed to be used.
- Pentax Medical: Endoscopy systems and accessories provider (HOYA Group) including GI scopes. Comparable as the second major GI endoscope platform vendor whose installed base defines the working-channel interface EGAD is designed to fit.
- Boston Scientific: Diversified interventional GI player with endoscopic resection, hemostasis, and tissue management products. Comparable as a broad incumbent in interventional GI with the strategic optionality to acquire or partner with emerging BE ablation assets like Digma.
- Steris: Post-Cantel integration, Steris distributes GI endoscopy infection-prevention and procedural consumables used in BE workflows. Comparable as an incumbent channel and consumables partner already present in BE-treating endoscopy suites.
Direct peers
- CSA Medical: Developer of the truFreeze spray cryotherapy system for esophageal disease including Barrett's Esophagus. Competes head-to-head with EGAD in the BE ablation indication via a different energy modality (cryo vs. laser).
Emerging players
- Creo Medical: UK-based developer of advanced energy endoscopic devices (Speedboat, CROMA) used in GI therapeutic procedures. Comparable as a developer of energy-based endoscopic therapeutic platforms targeting GI disease, though with a different mechanism and broader procedural scope.
- Fractyl Health: Clinical-stage company developing endoscopic GI interventions targeting metabolic disease (Type-2 Diabetes / NASH). Comparable to the short-description positioning Digma has publicly used around glycemic/NASH, and as an adjacent emerging endoscopic GI platform.
Others
- AngioDynamics: Acquired Digma co-founder Ilan Ben-Oren's prior company Eximo Medical, giving it direct familiarity with laser-based catheter ablation technology. Comparable as a strategic acquirer precedent for Digma's technology platform and a likely bidder at exit.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key highlights6 records
Customer concentration
Digma Medical social profiles
Digital presenceDigma Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Digma Medical leadership team
Management profileNumber of profiles
Profiles6 records
Digma Medical funding detail
Funding detailFunding overview
Funding rounds6 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Digma Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Digma Medical
What does Digma Medical do?
Digma Medical develops and intends to commercialize the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive, laser-based balloon-catheter system for treating Barrett's Esophagus. The system comprises an EGAD Console (capital equipment) and a single-use balloon catheter delivered through the working channel of standard GI endoscopes, enabling contactless, uniform, depth-controlled tissue ablation that protects deeper layers such as the muscularis. The product is currently investigational and not yet available for sale.
Is Digma Medical a public or private company?
Digma Medical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Digma Medical founded?
Digma Medical was founded in 2013. It employs 11 to 50 people.
Where is Digma Medical based?
Digma Medical is headquartered in Petah Tiqva, Israel, in the Middle East region.
How does Digma Medical make money?
Two revenue lines are on record. EGAD Console is the primary driver. The others are single-use Catheters.
Who are Digma Medical's main competitors?
Broad incumbents on record are Medtronic, ERBE Elektromedizin, Olympus Corporation, Pentax Medical, Boston Scientific and Steris. CSA Medical is listed as a direct peer. Emerging players are Creo Medical and Fractyl Health. AngioDynamics is listed as an others.
Does Digma Medical have an API?
No public API is recorded for Digma Medical.
What industry is Digma Medical in?
Digma Medical's product category is Endoscopic Gastrointestinal Ablation Devices. Its primary akta.pro industry code is HLAHADAN, Endoscopic Therapeutic & Access Devices (Trocars, dilators, biopsy/ablation tools), with a secondary code of HLAFAIAE, Endoscopy & GI Procedure Centers. Its NAICS code is 339112 and its SIC code is 3841.